CN Stock MarketDetailed Quotes

600664 Harbin Pharmaceutical Group

Watchlist
  • 3.96
  • +0.13+3.39%
Market Closed Dec 27 15:00 CST
9.97BMarket Cap16.30P/E (TTM)

Harbin Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Harbin Pharmaceutical Group Q3 2024 Earnings Date

Currency：CNYOct 26, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
4.11B
--
+8.54%
EPS
--
0.07
--
--
Analyst Rating
Strong Buy

Dec 28, 2024

Harbin Pharmaceutical Group Earnings Estimates

Revenue

EPS

EBIT

No Data

Harbin Pharmaceutical Group Earnings Reports

  • Report for the third quarter of 2024 of Harbin Pharmaceutical Group Co., Ltd.

    Oct 26 00:00

  • Hainan Pharmaceutical Group Co., Ltd. 2024 Semi-Annual Report

    Aug 23 00:00

  • 哈药集团股份有限公司2024年半年度报告_摘要

    Aug 23 00:00

  • Announcement of Half-Year Performance Forecast Increase for HAECO Group Co., Ltd. in 2024.

    Jul 10 00:00

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 28, 2024

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme Shuanghuanglian
    Shuanghuanglian
    Intraday+1.64%
    Revitalizing Tohoku
    Revitalizing Tohoku
    Intraday+1.00%
    Industrial Hemp
    Industrial Hemp
    Intraday+0.91%